封面
市场调查报告书
商品编码
1404785

糖尿病足溃疡治疗的全球市场:规模、份额和趋势分析报告 - 按治疗方法、按溃疡类型、按最终用途、按地区、细分市场预测,2024-2030 年

Diabetic Foot Ulcer Treatment Market Size, Share & Trends Analysis Report By Treatment (Biologics, Therapy Devices), By Ulcer Type (Ischemic, Neuropathic), By End-use (Hospitals, ASCs), By Region, And Segment Forecasts, 2024 - 2030

出版日期: | 出版商: Grand View Research | 英文 180 Pages | 商品交期: 2-10个工作天内

价格

糖尿病足溃疡治疗市场成长与趋势:

预计2030年,全球糖尿病足溃疡治疗市场规模将达77.6亿美元,2024年至2030年复合年增长率为6.0%。

糖尿病是该地区截肢、失明、中风、末期肾功能衰竭肾臟病、肾衰竭和心臟病的主要原因之一。根据国际糖尿病联盟的数据,2017 年欧洲约有 6,600 万人患有糖尿病。到 2045 年,这一数字预计将增至 8,100 万。前 12 个月内与 DFU 相关的死亡率约为 5%,5 年后增加至 42%。

许多辅助性治疗可以有效改善和治癒DFU,包括非手术清创剂、敷料、外用製剂、氧气疗法、负压伤口护理、细胞生技药品、人类生长因子、能量疗法和全身性治疗等。最近的研究表明,抑制有害的蛋白酶 MMP-9 酶可能会加速伤口癒合。亚洲地区久坐的生活方式、国内生产总值医疗保健支出不足、不健康的饮食习惯和报销情况不佳是导致该地区糖尿病高成长的因素。因此,在亚洲地区观察到了 DFU 的许多负面影响。

预计生技药品领域将在 2023 年占据最大的收益占有率,并在预测期内呈现最高的成长率。生技药品包括生长因子[如血管内皮生长因子(VEGF)和血小板衍生生长因子(PDGF)]、干细胞和其他抗糖尿病药物。这些药物有助于降低高血糖,增加氧气供应和循环,并修復失去的组织。因此,它越来越多地用于各个阶段的伤口处理,被认为是 DFU 治疗的理想选择。 2021年创伤护理敷料占据第二大销售份额,其次是治疗设备和抗生素製剂。

市场开拓公司不断开发新的和改进的产品,以缩短 DFU 的癒合时间。 ConvaTec, Inc.、Acelity LP Inc.、3M Healthcare、Coloplast Corp. 和 Smith & Nephew Plc. 等公司在该市场处于领先地位。儘管爆发了 COVID-19,但这些公司报告称,由于感染 COVID-19 的糖尿病患者併发症增加,对伤口处理产品的需求增加。据称,随着接受 COVID-19 治疗的患者血糖水平升高导致糖尿病的发生,该市场预计将在 2021 年稳步增长。例如,2020 年在义大利,接受 COVID-19给药的糖尿病患者整体比例在 5% 至 30% 之间。此外,Smith and Nephew 报告称,他们新推出的创伤治疗产品 PICO 7 的销售将在 2020 年突破 100 万件。因此,预计2020年市场将大幅成长,并在市场估计和预测期内保持稳定。

糖尿病足溃疡治疗市场报告亮点

  • 从治疗方法来看,由于创伤治疗时间缩短和血小板形成效率提高,生物製药产业在 2023 年占据了最大的销售份额。
  • 按溃疡类型划分,神经缺血性溃疡细分市场在 2023 年占据主要收益占有率。
  • 由于治疗采用率上升和经验丰富的员工增加,医院最终用途部门在 2023 年占据第二大收益占有率。
  • 由于市场参与者的存在以及治疗成本和报销方案的改善,北美在 2023 年获得了最大的收益占有率。

目录

第一章调查方法和范围

第 2 章执行摘要

第三章 糖尿病足溃疡治疗市场的变数与趋势

  • 市场体系展望
  • 市场动态
    • 市场驱动因素影响分析
    • 市场抑制因素影响分析
  • 产业分析工具
    • 波特的分析
    • 宏观经济分析
  • COVID-19 影响分析
    • 疫情后市场洞察
  • 供应链分析

第四章糖尿病足溃疡治疗市场:治疗方法分析

  • 治疗方法变化分析/市场占有率,2022-2030
  • 依治疗方法
  • 市场规模/预测、趋势分析,2018-2030
    • 创伤护理绷带
    • 生技药品
    • 治疗设备
    • 抗生素药物
    • 其他的

第五章糖尿病足溃疡治疗市场:类型分析

  • 类型变化分析/市场占有率,2022-2030
  • 按类型
  • 市场规模/预测、趋势分析,2018-2030
    • 神经病变溃疡
    • 缺血性溃疡
    • 神经缺血性溃疡

第六章糖尿病足溃疡治疗市场:最终用途分析

  • 最终用途变化分析/市场占有率,2022-2030
  • 按最终用途
  • 市场规模/预测、趋势分析,2018-2030
    • 医院
    • 门诊手术中心
    • 居家护理

第七章糖尿病足溃疡治疗市场:区域估计与趋势分析

  • 糖尿病足溃疡治疗市场:区域展望
  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 瑞典
    • 丹麦
    • 挪威
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中东/非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第八章竞争分析

  • 公司分类
  • 参与者概览
  • 财务绩效
  • 产品基准评效
  • 2023 年公司市场占有率分析
  • 公司市场分析
  • 策略规划
    • 併购
    • 新产品发布
    • 伙伴关係与协作
    • 扩张
    • 其他的
  • 公司简介
    • ConvaTec, Group Plc
    • Acelity LP, Inc.
    • 3M Health Care
    • Coloplast Corp.
    • Smith & Nephew Plc
    • B. Braun Melsungen AG
    • Medline Industries, LP.
    • Molnlycke Health Care AB
    • Medtronic Plc

第9章分析师的观点

Product Code: GVR-2-68038-742-1

Diabetic Foot Ulcer Treatment Market Growth & Trends:

The global diabetic foot ulcer treatment market size is expected to reach USD 7.76 billion by 2030, registering a CAGR of 6.0% from 2024 to 2030, according to a new report by Grand View Research, Inc. Diabetes is one of the major causes of amputation, blindness, stroke, end-stage renal failure, kidney failure, and heart attacks in this region. According to the International Diabetes Federation, ~66 million people were suffering from diabetes in Europe in 2017. The number is expected to increase to ~81 million by 2045. The mortality rate associated with DFU is ~5% in the first 12 months and increases up to 42% by the end of 5 years.

Many adjuvant therapies such as nonsurgical debridement agents, dressings and topical agents, oxygen therapies, negative pressure wound therapy, acellular bioproducts, human growth factors, energy-based therapies, and systemic therapies are said to effectively improve and cure DFU. Recent studies suggest that the inhibition of detrimental proteinase MMP-9 enzyme allows the body to heal the wound at a quicker rate. Sedentary lifestyle, poor GDP expenditure on healthcare, unhealthy food habits, and poor reimbursement scenarios in the Asian region are the factors responsible for the high growth of diabetes in this region. Hence, numerous ill effects of DFU are observed in the Asian region.

The biologics segment held the largest revenue share in 2023 and is expected to grow at the highest rate during the forecast period. Biologics include growth factors [such as Vascular Endothelial Growth Factor (VEGF) and Platelet-Derived Growth Factor (PDGF)], stem cells, and other anti-diabetic drugs. These agents help reduce hyperglycemia, increase oxygenation and circulation, and repair lost tissues. Therefore, they are increasingly being used for the management of wounds in different stages and are considered to be ideal for DFU treatment. Wound care dressings held the second-largest revenue share in 2021, followed by therapy devices and antibiotic medications.

Market players are constantly developing new and improved products to ensure quicker healing time for DFU. Companies like ConvaTec, Inc.; Acelity L.P. Inc.; 3M Healthcare; Coloplast Corp.; and Smith & Nephew Plc. are among the leaders in this market. Despite the COVID-19 outbreak, these players reported an increase in demand for their wound management products due to the increased complications of diabetic patients suffering from COVID-19 infection. The market was said to increase at a steady rate in 2021 as COVID-19 treated patients witnessed a rise in sugar levels leading to the onset of diabetes. For instance, the overall proportion of diabetic patients with COVID-19 ranged from 5% - 30% in Italy in 2020. Further, Smith and Nephew reported the sales of its newly launched wound healing product, PICO 7, to cross the 1 million mark in 2020. Hence, the market grew dramatically in 2020 and is estimated to stabilize during the forecast period.

Diabetic Foot Ulcer Treatment Market Report Highlights:

  • By treatment, the biologics segment captured the largest revenue share in 2023 owing to its reduced wound healing time and increased platelet formation efficiency
  • Based on ulcer type, the neuro-ischemic ulcers segment held the dominant revenue share in 2023
  • The hospitals end-use segment accounted for the second-largest revenue share in 2023 due to the increased adoption rate of treatment and highly experienced staff
  • North America grabbed the largest revenue share in 2023 due to the presence of market players and improved treatment cost and reimbursement scenario

Table of Contents

Chapter 1 Methodology And Scope

  • 1.1 Market Segmentation
  • 1.2 Market Definition
  • 1.3 Research Methodology
  • 1.4 Information Procurement
    • 1.4.1 Purchased Database
    • 1.4.2 Gvr's Internal Database
    • 1.4.3 Secondary Sources
    • 1.4.4 Primary Research
  • 1.5 Information Or Data Analysis
    • 1.5.1 Data Analysis Models
  • 1.6 Market Formulation & Validation
  • 1.7 Model Details
    • 1.7.1 Commodity Flow Analysis
  • 1.8 List Of Secondary Sources
  • 1.9 List Of Abbreviations
  • 1.10 Objectives
    • 1.10.1 Objective 1
    • 1.10.2 Objective 2
    • 1.10.3 Objective 3

Chapter 2 Executive Summary

  • 2.1 Market Snapshot (Regional)
  • 2.2 Segment Snapshot (Treatment And Type)
  • 2.3 Segment Snapshot (End-Use)
  • 2.4 Competitive Landscape

Chapter 3 Diabetic Foot Ulcer Treatment Market Variables And Trends

  • 3.1 Market Lineage Outlook
  • 3.2 Market Dynamics
    • 3.2.1 Market Driver Impact Analysis
      • 3.2.1.1 Growing Prevalence Of Diabetes
      • 3.2.1.2 Rising Geriatric Population
      • 3.2.1.3 Increasing Government Initiative
    • 3.2.2 Market Restraint Impact Analysis
      • 3.2.2.1 High Cost Of Treatment
  • 3.3 Industry Analysis Tools
    • 3.3.1 Porter's Analysis
    • 3.3.2 Macroeconomic Analysis
  • 3.4 Covid-19 Impact Analysis
    • 3.4.1 Post-Pandemic Market Insights
  • 3.5 Supply Chain Analysis

Chapter 4 Diabetic Foot Ulcer Treatment Market: Treatment Analysis

  • 4.1 Treatment Movement Analysis & Market Share, 2022 & 2030
  • 4.2 Diabetic Foot Ulcer Treatment Market Estimates & Forecast, By Treatment (USD Million)
  • 4.3 Market Size & Forecasts And Trend Analysis, 2018 To 2030
    • 4.3.1 Wound Care Dressings
      • 4.3.1.1 Wound Care Dressings Market, 2018 - 2030 (USD Million)
      • 4.3.1.2 Alginate Dressings
      • 4.3.1.2.1 Alginate Dressings Market, 2018 - 2030 (USD Million)
      • 4.3.1.3 Hydrofiber Dressings
      • 4.3.1.3.1 Hydrofiber Dressings Market, 2018 - 2030 (USD Million)
      • 4.3.1.4 Foam Dressings
      • 4.3.1.4.1 Foam Dressings Market, 2018 - 2030 (USD Million)
      • 4.3.1.5 Film Dressing
      • 4.3.1.5.1 Film Dressing Market, 2018 - 2030 (USD Million)
      • 4.3.1.6 Hydrocolloid Dressings
      • 4.3.1.6.1 Hydrocolloid Dressings Market, 2018 - 2030 (USD Million)
      • 4.3.1.7 Surgical Dressings
      • 4.3.1.7.1 Surgical Dressings Market, 2018 - 2030 (USD Million)
      • 4.3.1.8 Hydrogel Dressings
      • 4.3.1.8.1 Hydrogel Dressings Market, 2018 - 2030 (USD Million)
    • 4.3.2 Biologics
      • 4.3.2.1 Biologics Market, 2018 - 2030 (USD Million)
      • 4.3.2.2 Growth Factors
      • 4.3.2.2.1 Growth Factors Market, 2018 - 2030 (USD Million)
      • 4.3.2.3 Skin Grafts
      • 4.3.2.3.1 Skin Grafts Market, 2018 - 2030 (USD Million)
    • 4.3.3 Therapy Devices
      • 4.3.3.1 Therapy Devices Market, 2018 - 2030 (USD Million)
      • 4.3.3.2 Negative Pressure Wound Therapy
      • 4.3.3.2.1 Negative Pressure Wound Therapy Market, 2018 - 2030 (USD Million)
      • 4.3.3.3 Ultrasound Therapy
      • 4.3.3.3.1 Ultrasound Therapy Market, 2018 - 2030 (USD Million)
    • 4.3.4 Antibiotic Medications
      • 4.3.4.1 Antibiotic Medications Market, 2018 - 2030 (USD Million)
    • 4.3.5 Others
      • 4.3.5.1 Others Market, 2018 - 2030 (USD Million)

Chapter 5 Diabetic Foot Ulcer Treatment Market: Type Analysis

  • 5.1 Type Movement Analysis & Market Share, 2022 & 2030
  • 5.2 Diabetic Foot Ulcer Treatment Market Estimates & Forecast, By Type (USD Million)
  • 5.3 Market Size & Forecasts And Trend Analysis, 2018 To 2030
    • 5.3.1 Neuropathic Ulcers
      • 5.3.1.1 Neuropathic Ulcers Market, 2018 - 2030 (USD Million)
    • 5.3.2 Ischemic Ulcers
      • 5.3.2.1 Ischemic Ulcers Market, 2018 - 2030 (USD Million)
    • 5.3.3 Neuro-Ischemic Ulcers
      • 5.3.3.1 Neuro-Ischemic Ulcers Market, 2018 - 2030 (USD Million)

Chapter 6 Diabetic Foot Ulcer Treatment Market: End-Use Analysis

  • 6.1 End-Use Movement Analysis & Market Share, 2022 & 2030
  • 6.2 Diabetic Foot Ulcer Treatment Market Estimates & Forecast, By End-Use (USD Million)
  • 6.3 Market Size & Forecasts And Trend Analysis, 2018 To 2030
    • 6.3.1 Hospitals
      • 6.3.1.1 Hospitals Market, 2018 - 2030 (USD Million)
    • 6.3.2 Ambulatory Surgical Centers
      • 6.3.2.1 Ambulatory Surgical Centers Market, 2018 - 2030 (USD Million)
    • 6.3.3 Homecare
      • 6.3.3.1 Homecare Market, 2018 - 2030 (USD Million)

Chapter 7 Diabetic Foot Ulcer Treatment Market: Regional Estimates & Trend Analysis

  • 7.1 Diabetic Foot Ulcer Treatment Market: Regional Outlook
  • 7.2 North America
    • 7.2.1 North America Diabetic Foot Ulcer Treatment Market Estimates & Forecasts, 2018 - 2030 (USD Million)
    • 7.2.2 U.S.
      • 7.2.2.1 Key Country Dynamics
      • 7.2.2.2 Competitive Scenario
      • 7.2.2.3 Regulatory Framework
      • 7.2.2.4 Reimbursement Scenario
      • 7.2.2.5 U.S. Diabetic Foot Ulcer Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.2.3 Canada
      • 7.2.3.1 Key Country Dynamics
      • 7.2.3.2 Competitive Scenario
      • 7.2.3.3 Regulatory Framework
      • 7.2.3.4 Reimbursement Scenario
      • 7.2.3.5 Canada Diabetic Foot Ulcer Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.3 Europe
    • 7.3.1 Europe Diabetic Foot Ulcer Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.3.2 U.K
      • 7.3.2.1 Key Country Dynamics
      • 7.3.2.2 Competitive Scenario
      • 7.3.2.3 Regulatory Framework
      • 7.3.2.4 Reimbursement Scenario
      • 7.3.2.5 U.K Diabetic Foot Ulcer Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.3.3 Germany
      • 7.3.3.1 Key Country Dynamics
      • 7.3.3.2 Competitive Scenario
      • 7.3.3.3 Regulatory Framework
      • 7.3.3.4 Reimbursement Scenario
      • 7.3.3.5 Germany Diabetic Foot Ulcer Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.3.4 France
      • 7.3.4.1 Key Country Dynamics
      • 7.3.4.2 Competitive Scenario
      • 7.3.4.3 Regulatory Framework
      • 7.3.4.4 Reimbursement Scenario
      • 7.3.4.5 France Diabetic Foot Ulcer Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.3.5 Italy
      • 7.3.5.1 Key Country Dynamics
      • 7.3.5.2 Competitive Scenario
      • 7.3.5.3 Regulatory Framework
      • 7.3.5.4 Reimbursement Scenario
      • 7.3.5.5 Italy Diabetic Foot Ulcer Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.3.6 Spain
      • 7.3.6.1 Key Country Dynamics
      • 7.3.6.2 Competitive Scenario
      • 7.3.6.3 Regulatory Framework
      • 7.3.6.4 Reimbursement Scenario
      • 7.3.6.5 Spain Diabetic Foot Ulcer Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.3.7 Sweden
      • 7.3.7.1 Key Country Dynamics
      • 7.3.7.2 Competitive Scenario
      • 7.3.7.3 Regulatory Framework
      • 7.3.7.4 Reimbursement Scenario
      • 7.3.7.5 Sweden Diabetic Foot Ulcer Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.3.8 Denmark
      • 7.3.8.1 Key Country Dynamics
      • 7.3.8.2 Competitive Scenario
      • 7.3.8.3 Regulatory Framework
      • 7.3.8.4 Reimbursement Scenario
      • 7.3.8.5 Denmark Diabetic Foot Ulcer Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.3.9 Norway
      • 7.3.9.1 Key Country Dynamics
      • 7.3.9.2 Competitive Scenario
      • 7.3.9.3 Regulatory Framework
      • 7.3.9.4 Reimbursement Scenario
      • 7.3.9.5 Norway Diabetic Foot Ulcer Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.4 Asia Pacific
    • 7.4.1 Asia Pacific Diabetic Foot Ulcer Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.4.2 Japan
      • 7.4.2.1 Key Country Dynamics
      • 7.4.2.2 Competitive Scenario
      • 7.4.2.3 Regulatory Framework
      • 7.4.2.4 Reimbursement Scenario
      • 7.4.2.5 Japan Diabetic Foot Ulcer Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.4.3 China
      • 7.4.3.1 Key Country Dynamics
      • 7.4.3.2 Competitive Scenario
      • 7.4.3.3 Regulatory Framework
      • 7.4.3.4 Reimbursement Scenario
      • 7.4.3.5 China Diabetic Foot Ulcer Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.4.4 India
      • 7.4.4.1 Key Country Dynamics
      • 7.4.4.2 Competitive Scenario
      • 7.4.4.3 Regulatory Framework
      • 7.4.4.4 Reimbursement Scenario
      • 7.4.4.5 India Diabetic Foot Ulcer Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.4.5 Australia
      • 7.4.5.1 Key Country Dynamics
      • 7.4.5.2 Competitive Scenario
      • 7.4.5.3 Regulatory Framework
      • 7.4.5.4 Reimbursement Scenario
      • 7.4.5.5 Australia Diabetic Foot Ulcer Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.4.6 South Korea
      • 7.4.6.1 Key Country Dynamics
      • 7.4.6.2 Competitive Scenario
      • 7.4.6.3 Regulatory Framework
      • 7.4.6.4 Reimbursement Scenario
      • 7.4.6.5 South Korea Diabetic Foot Ulcer Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.4.7 Thailand
      • 7.4.7.1 Key Country Dynamics
      • 7.4.7.2 Competitive Scenario
      • 7.4.7.3 Regulatory Framework
      • 7.4.7.4 Reimbursement Scenario
      • 7.4.7.5 Thailand Diabetic Foot Ulcer Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.5 Latin America
    • 7.5.1 Latin America Diabetic Foot Ulcer Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.2 Brazil
      • 7.5.2.1 Key Country Dynamics
      • 7.5.2.2 Competitive Scenario
      • 7.5.2.3 Regulatory Framework
      • 7.5.2.4 Reimbursement Scenario
      • 7.5.2.5 Brazil Diabetic Foot Ulcer Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.3 Mexico
      • 7.5.3.1 Key Country Dynamics
      • 7.5.3.2 Competitive Scenario
      • 7.5.3.3 Regulatory Framework
      • 7.5.3.4 Reimbursement Scenario
      • 7.5.3.5 Mexico Diabetic Foot Ulcer Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.4 Argentina
      • 7.5.4.1 Key Country Dynamics
      • 7.5.4.2 Competitive Scenario
      • 7.5.4.3 Regulatory Framework
      • 7.5.4.4 Reimbursement Scenario
      • 7.5.4.5 Argentina Diabetic Foot Ulcer Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.6 Middle East & Africa
    • 7.6.1 Middle East & Africa Diabetic Foot Ulcer Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.6.2 South Africa
      • 7.6.2.1 Key Country Dynamics
      • 7.6.2.2 Competitive Scenario
      • 7.6.2.3 Regulatory Framework
      • 7.6.2.4 Reimbursement Scenario
      • 7.6.2.5 South Africa Diabetic Foot Ulcer Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.6.3 Saudi Arabia
      • 7.6.3.1 Key Country Dynamics
      • 7.6.3.2 Competitive Scenario
      • 7.6.3.3 Regulatory Framework
      • 7.6.3.4 Reimbursement Scenario
      • 7.6.3.5 Saudi Arabia Diabetic Foot Ulcer Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.6.4 UAE
      • 7.6.4.1 Key Country Dynamics
      • 7.6.4.2 Competitive Scenario
      • 7.6.4.3 Regulatory Framework
      • 7.6.4.4 Reimbursement Scenario
      • 7.6.4.5 UAE Diabetic Foot Ulcer Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.6.5 Kuwait
      • 7.6.5.1 Key Country Dynamics
      • 7.6.5.2 Competitive Scenario
      • 7.6.5.3 Regulatory Framework
      • 7.6.5.4 Reimbursement Scenario
      • 7.6.5.5 Kuwait Diabetic Foot Ulcer Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 8 Competitive Analysis

  • 8.1 Company Categorization
  • 8.2 Participants' Overview
  • 8.3 Financial Performance
  • 8.4 Product Benchmarking
  • 8.5 Company Market Share Analysis, 2023
  • 8.6 Company Market Position Analysis
  • 8.7 Strategy Mapping
    • 8.7.1 Mergers & Acquisitions
    • 8.7.2 New Product Launch
    • 8.7.3 Partnerships & Collaborations
    • 8.7.4 Expansion
    • 8.7.5 Others
  • 8.8 Company Profiles
    • 8.8.1 ConvaTec, Group Plc
      • 8.8.1.1 Company overview
      • 8.8.1.2 Finacial performance
      • 8.8.1.3 Product benchmarking
      • 8.8.1.4 Strategic initiatives
    • 8.8.2 Acelity L.P., Inc.
      • 8.8.2.1 Company overview
      • 8.8.2.2 Finacial performance
      • 8.8.2.3 Product benchmarking
      • 8.8.2.4 Strategic initiatives
    • 8.8.3 3M Health Care
      • 8.8.3.1 Company overview
      • 8.8.3.2 Finacial performance
      • 8.8.3.3 Product benchmarking
      • 8.8.3.4 Strategic initiatives
    • 8.8.4 Coloplast Corp.
      • 8.8.4.1 Company overview
      • 8.8.4.2 Finacial performance
      • 8.8.4.3 Product benchmarking
      • 8.8.4.4 Strategic initiatives
    • 8.8.5 Smith & Nephew Plc
      • 8.8.5.1 Company overview
      • 8.8.5.2 Finacial performance
      • 8.8.5.3 Product benchmarking
      • 8.8.5.4 Strategic initiatives
    • 8.8.6 B. Braun Melsungen AG
      • 8.8.6.1 Company overview
      • 8.8.6.2 Finacial performance
      • 8.8.6.3 Product benchmarking
      • 8.8.6.4 Strategic initiatives
    • 8.8.7 Medline Industries, LP.
      • 8.8.7.1 Company overview
      • 8.8.7.2 Finacial performance
      • 8.8.7.3 Product benchmarking
      • 8.8.7.4 Strategic initiatives
    • 8.8.8 Molnlycke Health Care AB
      • 8.8.8.1 Company overview
      • 8.8.8.2 Finacial performance
      • 8.8.8.3 Product benchmarking
      • 8.8.8.4 Strategic initiatives
    • 8.8.9 Medtronic Plc
      • 8.8.9.1 Company overview
      • 8.8.9.2 Finacial performance
      • 8.8.9.3 Product benchmarking
      • 8.8.9.4 Strategic initiatives

Chapter 9 Analyst Perspective

List of Tables

  • Table 1. List of secondary sources
  • Table 2. List of abbreviation
  • Table 3. North America diabetic foot ulcer market, By country, 2018 - 2030 (USD Million)
  • Table 4. North America diabetic foot ulcer market, By treatment, 2018 - 2030 (USD Million)
  • Table 5. North America diabetic foot ulcer market, By ulcer type, 2018 - 2030 (USD Million)
  • Table 6. North America diabetic foot ulcer market, By end-use, 2018 - 2030 (USD Million)
  • Table 7. U.S. diabetic foot ulcer market, By treatment, 2018 - 2030 (USD Million)
  • Table 8. U.S. diabetic foot ulcer market, By ulcer type, 2018 - 2030 (USD Million)
  • Table 9. U.S. diabetic foot ulcer market, By end-use, 2018 - 2030 (USD Million)
  • Table 10. Canada diabetic foot ulcer market, By treatment, 2018 - 2030 (USD Million)
  • Table 11. Canada diabetic foot ulcer market, By ulcer type, 2018 - 2030 (USD Million)
  • Table 12. Canada diabetic foot ulcer market, By end-use, 2018 - 2030 (USD Million)
  • Table 13. Europe diabetic foot ulcer market, By country, 2018 - 2030 (USD Million)
  • Table 14. Europe diabetic foot ulcer market, By treatment, 2018 - 2030 (USD Million)
  • Table 15. Europe diabetic foot ulcer market, By ulcer type, 2018 - 2030 (USD Million)
  • Table 16. Europe diabetic foot ulcer market, By end-use, 2018 - 2030 (USD Million)
  • Table 17. UK diabetic foot ulcer market, By treatment, 2018 - 2030 (USD Million)
  • Table 18. UK diabetic foot ulcer market, By ulcer type, 2018 - 2030 (USD Million)
  • Table 19. UK diabetic foot ulcer market, By end-use, 2018 - 2030 (USD Million)
  • Table 20. Germany diabetic foot ulcer market, By treatment, 2018 - 2030 (USD Million)
  • Table 21. Germany diabetic foot ulcer market, By ulcer type, 2018 - 2030 (USD Million)
  • Table 22. Germany diabetic foot ulcer market, By end-use, 2018 - 2030 (USD Million)
  • Table 23. France diabetic foot ulcer market, By treatment, 2018 - 2030 (USD Million)
  • Table 24. France diabetic foot ulcer market, By ulcer type, 2018 - 2030 (USD Million)
  • Table 25. France diabetic foot ulcer market, By end-use, 2018 - 2030 (USD Million)
  • Table 26. Italy diabetic foot ulcer market, By treatment, 2018 - 2030 (USD Million)
  • Table 27. Italy diabetic foot ulcer market, By ulcer type, 2018 - 2030 (USD Million)
  • Table 28. Italy diabetic foot ulcer market, By end-use, 2018 - 2030 (USD Million)
  • Table 29. Denmark diabetic foot ulcer market, By treatment, 2018 - 2030 (USD Million)
  • Table 30. Denmark diabetic foot ulcer market, By ulcer type, 2018 - 2030 (USD Million)
  • Table 31. Denmark diabetic foot ulcer market, By end-use, 2018 - 2030 (USD Million)
  • Table 32. Sweden diabetic foot ulcer market, By treatment, 2018 - 2030 (USD Million)
  • Table 33. Sweden diabetic foot ulcer market, By ulcer type, 2018 - 2030 (USD Million)
  • Table 34. Sweden diabetic foot ulcer market, By end-use, 2018 - 2030 (USD Million)
  • Table 35. Norway diabetic foot ulcer market, By treatment, 2018 - 2030 (USD Million)
  • Table 36. Norway diabetic foot ulcer market, By ulcer type, 2018 - 2030 (USD Million)
  • Table 37. Norway diabetic foot ulcer market, By end-use, 2018 - 2030 (USD Million)
  • Table 38. Asia Pacific diabetic foot ulcer market, By country, 2018 - 2030 (USD Million)
  • Table 39. Asia Pacific diabetic foot ulcer market, By treatment, 2018 - 2030 (USD Million)
  • Table 40. Asia Pacific diabetic foot ulcer market, By ulcer type, 2018 - 2030 (USD Million)
  • Table 41. Asia Pacific diabetic foot ulcer market, By end-use, 2018 - 2030 (USD Million)
  • Table 42. Japan diabetic foot ulcer market, By treatment, 2018 - 2030 (USD Million)
  • Table 43. Japan diabetic foot ulcer market, By ulcer type, 2018 - 2030 (USD Million)
  • Table 44. Japan diabetic foot ulcer market, By end-use, 2018 - 2030 (USD Million)
  • Table 45. China diabetic foot ulcer market, By treatment, 2018 - 2030 (USD Million)
  • Table 46. China diabetic foot ulcer market, By ulcer type, 2018 - 2030 (USD Million)
  • Table 47. China diabetic foot ulcer market, By end-use, 2018 - 2030 (USD Million)
  • Table 48. India diabetic foot ulcer market, By treatment, 2018 - 2030 (USD Million)
  • Table 49. India diabetic foot ulcer market, By ulcer type, 2018 - 2030 (USD Million)
  • Table 50. India diabetic foot ulcer market, By end-use, 2018 - 2030 (USD Million)
  • Table 51. Australia diabetic foot ulcer market, By treatment, 2018 - 2030 (USD Million)
  • Table 52. Australia diabetic foot ulcer market, By ulcer type, 2018 - 2030 (USD Million)
  • Table 53. Australia diabetic foot ulcer market, By end-use, 2018 - 2030 (USD Million)
  • Table 54. South Korea diabetic foot ulcer market, By treatment, 2018 - 2030 (USD Million)
  • Table 55. South Korea diabetic foot ulcer market, By ulcer type, 2018 - 2030 (USD Million)
  • Table 56. South Korea diabetic foot ulcer market, By end-use, 2018 - 2030 (USD Million)
  • Table 57. Thailand diabetic foot ulcer market, By treatment, 2018 - 2030 (USD Million)
  • Table 58. Thailand diabetic foot ulcer market, By ulcer type, 2018 - 2030 (USD Million)
  • Table 59. Thailand diabetic foot ulcer market, By end-use, 2018 - 2030 (USD Million)
  • Table 60. Latin America diabetic foot ulcer market, By Country, 2018 - 2030 (USD Million)
  • Table 61. Latin America diabetic foot ulcer market, By treatment, 2018 - 2030 (USD Million)
  • Table 62. Latin America diabetic foot ulcer market, By ulcer type, 2018 - 2030 (USD Million)
  • Table 63. Latin America diabetic foot ulcer market, By end-use, 2018 - 2030 (USD Million)
  • Table 64. Brazil diabetic foot ulcer market, By treatment, 2018 - 2030 (USD Million)
  • Table 65. Brazil diabetic foot ulcer market, By ulcer type, 2018 - 2030 (USD Million)
  • Table 66. Brazil diabetic foot ulcer market, By end-use, 2018 - 2030 (USD Million)
  • Table 67. Mexico diabetic foot ulcer market, By treatment, 2018 - 2030 (USD Million)
  • Table 68. Mexico diabetic foot ulcer market, By ulcer type, 2018 - 2030 (USD Million)
  • Table 69. Mexico diabetic foot ulcer market, By end-use, 2018 - 2030 (USD Million)
  • Table 70. Argentina diabetic foot ulcer market, By treatment, 2018 - 2030 (USD Million)
  • Table 71. Argentina diabetic foot ulcer market, By ulcer type, 2018 - 2030 (USD Million)
  • Table 72. Argentina diabetic foot ulcer market, By end-use, 2018 - 2030 (USD Million)
  • Table 73. Middle East & Africa diabetic foot ulcer market, By country, 2018 - 2030 (USD Million)
  • Table 74. Middle East & Africa diabetic foot ulcer market, By treatment, 2018 - 2030 (USD Million)
  • Table 75. Middle East & Africa diabetic foot ulcer market, By ulcer type, 2018 - 2030 (USD Million)
  • Table 76. Middle East & Africa diabetic foot ulcer market, By end-use, 2018 - 2030 (USD Million)
  • Table 77. South Africa diabetic foot ulcer market, By treatment, 2018 - 2030 (USD Million)
  • Table 78. South Africa diabetic foot ulcer market, By ulcer type, 2018 - 2030 (USD Million)
  • Table 79. South Africa diabetic foot ulcer market, By end-use, 2018 - 2030 (USD Million)
  • Table 80. Saudi Arabia diabetic foot ulcer market, By treatment, 2018 - 2030 (USD Million)
  • Table 81. Saudi Arabia diabetic foot ulcer market, By ulcer type, 2018 - 2030 (USD Million)
  • Table 82. Saudi Arabia diabetic foot ulcer market, By end-use, 2018 - 2030 (USD Million)
  • Table 83. UAE diabetic foot ulcer market, By treatment, 2018 - 2030 (USD Million)
  • Table 84. UAE diabetic foot ulcer market, By ulcer type, 2018 - 2030 (USD Million)
  • Table 85. UAE diabetic foot ulcer market, By end-use, 2018 - 2030 (USD Million)
  • Table 86. Kuwait diabetic foot ulcer market, By treatment, 2018 - 2030 (USD Million)
  • Table 87. Kuwait diabetic foot ulcer market, By ulcer type, 2018 - 2030 (USD Million)
  • Table 88. Kuwait diabetic foot ulcer market, By end-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Diabetic foot ulcer treatment market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Market snapshot
  • Fig. 10 Segment snapshot (Treatment & type)
  • Fig. 11 Segment snapshot (End-use)
  • Fig. 12 Competitive landscape
  • Fig. 13 Wound care market value, 2023 (USD Billion)
  • Fig. 14 Diabetic foot ulcer treatment market dynamics
  • Fig. 15 Number of deaths before the age of 60 due to diabetes worldwide in 2021, by Region (in thousands)
  • Fig. 16 Projections of older adult population in the U.S.: 2020 to 2060
  • Fig. 17 Diabetic foot ulcer treatment market: PORTER's analysis
  • Fig. 18 Diabetic foot ulcer treatment market: PESTEL analysis
  • Fig. 19 Diabetic foot ulcer treatment market: by treatment: Key takeaways
  • Fig. 20 Diabetic foot ulcer treatment market, by treatment: Market share, 2023 & 2030
  • Fig. 21 Wound care dressings market, 2018 - 2030 (USD Million)
  • Fig. 22 Alginate dressings market, 2018 - 2030 (USD Million)
  • Fig. 23 Hydrofiber dressings market, 2018 - 2030 (USD Million)
  • Fig. 24 Foam dressings market, 2018 - 2030 (USD Million)
  • Fig. 25 Film dressing market, 2018 - 2030 (USD Million)
  • Fig. 26 Hydrocolloid dressings market, 2018 - 2030 (USD Million)
  • Fig. 27 Surgical dressings market, 2018 - 2030 (USD Million)
  • Fig. 28 Hydrogel dressings market, 2018 - 2030 (USD Million)
  • Fig. 29 Biologics market, 2018 - 2030 (USD Million)
  • Fig. 30 Growth factors market, 2018 - 2030 (USD Million)
  • Fig. 31 Skin grafts market, 2018 - 2030 (USD Million)
  • Fig. 32 Therapy devices market, 2018 - 2030 (USD Million)
  • Fig. 33 Negative pressure wound therapy market, 2018 - 2030 (USD Million)
  • Fig. 34 Ultrasound therapy market, 2018 - 2030 (USD Million)
  • Fig. 35 Antibiotic medications market, 2018 - 2030 (USD Million)
  • Fig. 36 Others market, 2018 - 2030 (USD Million)
  • Fig. 37 Diabetic foot ulcer treatment market: by type: Key takeaways
  • Fig. 38 Diabetic foot ulcer treatment market, by type: Market share, 2023 & 2030
  • Fig. 39 Neuropathic ulcers market, 2018 - 2030 (USD Million)
  • Fig. 40 Ischemic ulcers market, 2018 - 2030 (USD Million)
  • Fig. 41 Neuro-ischemic ulcers market, 2018 - 2030 (USD Million)
  • Fig. 42 Diabetic foot ulcer treatment market: by end-use: Key takeaways
  • Fig. 43 Diabetic foot ulcer treatment market, by end-use: Market share, 2023 & 2030
  • Fig. 44 Hospitals market, 2018 - 2030 (USD Million)
  • Fig. 45 Ambulatory surgical centers market, 2018 - 2030 (USD Million)
  • Fig. 46 Homecare market, 2018 - 2030 (USD Million)
  • Fig. 47 Diabetic foot ulcer treatment market revenue, by region, 2023 & 2030 (USD Million)
  • Fig. 48 Regional marketplace: Key takeaways
  • Fig. 49 Regional marketplace: Key takeaways
  • Fig. 50 North America diabetic foot ulcer treatment market estimates & forecast, 2018 - 2030 (USD Million)
  • Fig. 51 Key country dynamics
  • Fig. 52 Reimbursement scenario
  • Fig. 53 U.S. diabetic foot ulcer treatment market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Key country dynamics
  • Fig. 55 Canada diabetic foot ulcer treatment market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Europe diabetic foot ulcer treatment market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Key country dynamics
  • Fig. 58 UK diabetic foot ulcer treatment market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 Key country dynamics
  • Fig. 60 Germany diabetic foot ulcer treatment market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 Key country dynamics
  • Fig. 62 France diabetic foot ulcer treatment market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 63 Key country dynamics
  • Fig. 64 Italy diabetic foot ulcer treatment market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 65 Key country dynamics
  • Fig. 66 Spain diabetic foot ulcer treatment market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 67 Key country dynamics
  • Fig. 68 Sweden diabetic foot ulcer treatment market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 69 Key country dynamics
  • Fig. 70 Denmark diabetic foot ulcer treatment market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 71 Key country dynamics
  • Fig. 72 Norway diabetic foot ulcer treatment market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 73 Asia Pacific diabetic foot ulcer treatment market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 74 Key country dynamics
  • Fig. 75 Reimbursement procurement process
  • Fig. 76 Japan diabetic foot ulcer treatment market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 77 Key country dynamics
  • Fig. 78 China diabetic foot ulcer treatment market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 79 Key country dynamics
  • Fig. 80 India diabetic foot ulcer treatment market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 81 Key country dynamics
  • Fig. 82 Australia diabetic foot ulcer treatment market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 83 Key country dynamics
  • Fig. 84 South Korea diabetic foot ulcer treatment market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 85 Key country dynamics
  • Fig. 86 Thailand diabetic foot ulcer treatment market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 87 Latin America diabetic foot ulcer treatment market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 88 Key country dynamics
  • Fig. 89 Brazil diabetic foot ulcer treatment market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 90 Key country dynamics
  • Fig. 91 Mexico diabetic foot ulcer treatment market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 92 Key country dynamics
  • Fig. 93 Argentina diabetic foot ulcer treatment market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 94 Middle East & Africa diabetic foot ulcer treatment market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 95 Key country dynamics
  • Fig. 96 South Africa diabetic foot ulcer treatment market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 97 Key country dynamics
  • Fig. 98 Saudi Arabia diabetic foot ulcer treatment market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 99 Key country dynamics
  • Fig. 100 UAE diabetic foot ulcer treatment market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 101 Key country dynamics
  • Fig. 102 Kuwait diabetic foot ulcer treatment market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 103 Key company categorization
  • Fig. 104 Company market share analysis, 2023
  • Fig. 105 Company market position analysis
  • Fig. 106 Strategy mapping